S018 Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
DESCRIPTION
This is a case-based discussion of complex dermatologic problems that have systemic implications. We will utilize an Audience Response System for this session and therefore, Handouts will NOT be provided prior to the session. Speakers will be asked to upload a handout after the session.
LEARNING OBJECTIVES
Diagnose skin diseases that are associated with internal manifestations more effectively.
Develop an appropriate, yet cost effective, method of evaluation for patient with complex medical/dermatological disease.
Formulate an evidence-based management plan for patients with complex medical/dermatological disease.
SCHEDULE
1:00 PM
Introduction
Jeffrey Phillip Callen, MD, FAAD
1:05 PM
Case 1
Jean L Bolognia, MD, FAAD
1:20 PM
Case 2
Cindy Owen, MD, FAAD
1:35 PM
Case 3
Andrea Tesvich Murina, MD, FAAD
1:50 PM
Q & A
Cindy Owen, MD, FAAD, Andrea Tesvich Murina, MD, FAAD, Jean L Bolognia, MD, FAAD
2:00 PM
Case 4
Courtney Reynolds Schadt, MD, FAAD
2:15 PM
Case 5
Nicole Fett, MD, FAAD
2:30 PM
Case 6
Kanade Shinkai, MD, PhD, FAAD
2:45 PM
Q & A
Nicole Fett, MD, FAAD, Courtney Reynolds Schadt, MD, FAAD, Kanade Shinkai, MD, PhD, FAAD
2:55 PM
Case 7
Bridget Shields, MD, FAAD
3:10 PM
Case 8
Frank Wang, MD, FAAD
3:25 PM
Case 9
Milan J Anadkat, MD, FAAD
3:40 PM
Case 10
Lauren Michelle Madigan, MD, FAAD
3:55 PM
Q & A
Lauren Michelle Madigan, MD, FAAD, Frank Wang, MD, FAAD, Milan J Anadkat, MD, FAAD, Bridget Shields, MD, FAAD
DIRECTOR
Jeffrey Phillip Callen, MD, FAAD
SPEAKERS
Milan J Anadkat, MD, FAAD
Jean L Bolognia, MD, FAAD
Nicole Fett, MD, FAAD
Lauren Michelle Madigan, MD, FAAD
Andrea Tesvich Murina, MD, FAAD
Cindy Owen, MD, FAAD
Courtney Reynolds Schadt, MD, FAAD
Bridget Shields, MD, FAAD
Kanade Shinkai, MD, PhD, FAAD
Frank Wang, MD, FAAD
DISCLOSURES
Milan J Anadkat, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Fees); Eli Lilly – Advisory Board(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); Merus B.V. – Consultant (1099 relationship)(Fees); Novartis – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Jean L Bolognia, MD, FAAD
Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Jeffrey Phillip Callen, MD, FAAD
3M Pharmaceuticals – Stockholder Public Company(No Compensation Received); Abbott Laboratories – Stockholder Public Company(No Compensation Received); AbbVie – Stockholder Public Company(No Compensation Received); Allergan, Inc – Stockholder Public Company(No Compensation Received); Amgen – Stockholder Public Company(No Compensation Received); Biogen – Data Safety Monitoring Board(Honoraria); Celgene – Stockholder Public Company(No Compensation Received); Elsevier Inc. – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Johnson and Johnson – Stockholder Public Company(No Compensation Received); Merck & Co., Inc – Stockholder Public Company(No Compensation Received); Pfizer Inc. – Stockholder Public Company(No Compensation Received); Procter & Gamble Company – Stockholder Public Company(No Compensation Received); Proivant – Data Safety Monitoring Board(Fees); UpToDate, Inc. – Other(Honoraria);
Nicole Fett, MD, FAAD
Astra Zeneca – Investigator(Fees); UpToDate – Other(Honoraria);
Lauren Michelle Madigan, MD, FAAD
Blueprint Medicines – Advisory Board(Honoraria);
Andrea Tesvich Murina, MD, FAAD
AbbVie – Speaker(Honoraria); Amgen – Speaker(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Botanix Pharmaceuticals – Speaker(Honoraria); Bristol-Myers Squibb – Speaker(Honoraria); Eli Lilly and Company – Speaker(Honoraria); Galderma – Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Novartis – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria), Speaker(Honoraria); Pfizer Inc. – Speaker(Honoraria); Takeda Pharmaceuticals USA Inc – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); UCB Pharma – Speaker(Honoraria);
Cindy Owen, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Acrotech Biopharma Inc – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Bausch Health – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Connect Biopharma LLC – Investigator(Grants/Research Funding); Dermavant Sciences, Inc. – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Forte – Investigator(Grants/Research Funding); Galderma USA – Investigator(Grants/Research Funding); Horizon Therapeutics USA, Inc – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); janssen – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding);
Courtney Reynolds Schadt, MD, FAAD
No financial relationships exist with ineligible companies.
Bridget Shields, MD, FAAD
Arcutis Biotherapeutics – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria); UpToDate, Inc – Other(Honoraria);
Kanade Shinkai, MD, PhD, FAAD
No financial relationships exist with ineligible companies.
Frank Wang, MD, FAAD
Allergan – Investigator(Grants/Research Funding); ET Browne Drug Co Inc – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Linkou Chang Gung Memorial Hospital (Taiwan) – Investigator(Grants/Research Funding);